Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7) is a fully human monoclonal immunoglobulin G2 antibody that targets the alpha4beta7 Integrin and prevents interaction with MADCAM-1. It has the potential to be used in research on inflammatory bowel disease (IBD). MW: 143.8 kD.
| Name | Citation | Integrin |
|---|---|---|
| Cilengitide trifluoroacetate | 70 | |
| A-205804 | 6 | |
| Cyclo(RGDyK) TFA | 14 | |
| SB273005 | 27 | |
| RGD peptide (Arg-Gly-Asp) | 26 | |
| ATN-161 | 22 | |
| Cyclo(-RGDfK) TFA | 13 |
| Description |
Abrilumab (Anti-Integrin a4b7 ITGA4 & ITGB7) is a fully human monoclonal immunoglobulin G2 antibody that targets the alpha4beta7 Integrin and prevents interaction with MADCAM-1. It has the potential to be used in research on inflammatory bowel disease (IBD). MW: 143.8 kD.
|
References |
|---|
| CAS No. | 1342290-43-0 |
|---|---|
| Molecular Weight | 143.8 |
| Isotype | Human IgG2 |
| Source | CHO |
| Purification | AKTA |
| Sterility | 0.2 μM filtered |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage | Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Sellecks selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.